EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
182 hedge funds and large institutions have $679M invested in Eagle Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 61 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 61
47% less call options, than puts
Call options by funds: $4.74M | Put options by funds: $9M
Holders
182
Holding in Top 10
3
Calls
$4.74M
Puts
$9M
Top Buyers
| 1 | +$8.42M | |
| 2 | +$5.49M | |
| 3 | +$4.48M | |
| 4 |
SCM
Sio Capital Management
New York
|
+$4.28M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.98M |
Top Sellers
| 1 | -$9.55M | |
| 2 | -$8.81M | |
| 3 | -$6.5M | |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$5.92M |
| 5 |
Citigroup
New York
|
-$5.36M |